The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Health state preferences associated with subcutaneous injections and intravenous infusions for treatment of bone metastases.
Louis S. Matza
Research Funding - Amgen
Ze Cong
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Karen Chung
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Alison Stopeck
Consultant or Advisory Role - Amgen; Novartis
Research Funding - Amgen; Novartis
Katia Sonia Tonkin
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Amgen
Janet Elizabeth Brown
Consultant or Advisory Role - Amgen
Honoraria - Amgen; Novartis
Research Funding - Amgen; Novartis
Ada H. Braun
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Kate Van Brunt
No relevant relationships to disclose
Kelly McDaniel
Research Funding - Amgen